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Abstract
Objective. This manuscript reviews high-impact,
peer-reviewed studies published from January 2014
to March 2016 that are relevant to pain management
in primary care. Given the recent release of the US
Centers for Disease Control and Prevention’s
“Guideline for Prescribing Opioids for Chronic
Pain” emphasizing the primacy of nonopioid treat-
ment, we focused our review on nonopioid pain
management.
Design. Narrative review of peer-reviewed literature.
Methods. We searched three article summary ser-
vices and queried expert contacts for high-impact,
English-language studies related to the manage-
ment of pain in adults in primary care. All authors
reviewed 142 study titles to arrive at group consen-
sus on article content domains. Within article
domains, individual authors selected studies ap-
proved by the larger group according to their impact
on primary care clinical practice, policy, and re-
search, as well as quality of the study methods.
Through iterative discussion, 12 articles were se-
lected for detailed review, discussion, and presenta-
tion in this narrative review.
Results. We present key articles addressing each of
six domains of pain management: pharmacotherapy
for acute pain; interventional treatments; medical
cannabis; complementary and integrative medicine;
care management in chronic pain; and prevention.
Within each section, we conclude with implications
for pain management in primary care.
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Conclusions. There is growing evidence for multi-
ple nonopioid treatment modalities available to cli-
nicians for the management of pain in primary care.
The dissemination and implementation of these
studies, including innovative care management in-
terventions, warrant additional study and support
from clinicians, educators, and policy-makers.
Key Words. Pain Management; Primary Care;
Complementary and Integrative Health;
Interventional Pain Management
Introduction
Primary care providers treat the majority of patients with
chronic pain, and the US Department of Health and Human
Services’ (HHS) National Pain Strategy has recognized pri-
mary care as the hub of pain assessment and treatment in
the United States [1]. However, HHS acknowledged that
many primary care providers receive inadequate training in
pain management and feel unprepared to handle the com-
plex issues inherent in caring for patients with chronic pain.
On the other hand, as experts in prevention and chronic dis-
ease management increasingly trained in team-based care,
primary care providers are uniquely positioned to deliver the
biopsychosocially oriented, evidence-based pain care pro-
moted in the National Pain Strategy. Our aims were to re-
view recent high-impact pain medicine studies relevant to
primary care. Given the recent release of the US Centers for
Disease Control and Prevention’s (CDC’s) “Guideline for
Prescribing Opioids for Chronic Pain” emphasizing that
“non-opioid therapy is preferred for treatment of chronic
pain” [2], we focused our review on nonopioid pain
management.
Methods
We identified peer-reviewed articles relevant to pain
management in primary care published from January 1,
2014, through March 31, 2016. We first reviewed sum-
maries of high-impact studies identified by McMaster/
BMJ’s Evidence Updates as relevant to primary care or
pain specialty providers. The McMaster/BMJ’s Evidence
Updates systematically reviews over 120 journals includ-
ing the Cochrane library and pain specialty journals. We
further searched New England Journal of Medicine’s
Journal Watch and the American College of Physicians’
Journal Club for summaries of potentially relevant stud-
ies. Additionally, we invited members of the Society of
General Internal Medicine’s Pain Medicine Interest
Group—approximately 60 generalists with interest and
expertise in pain management—to suggest relevant arti-
cles. This search strategy produced 142 references, the
titles and abstracts of which were further assessed for
inclusion by all authors according to relevance to pain
management for primary care providers. This review and
subsequent discussion was carried out in a series of
three conference calls and led to group consensus on
the most important article content domains. Within do-
mains, individual authors selected and presented the
most important studies for group discussion and ap-
proval based on potential impact on primary care prac-
tice, policy, and research, as well as the quality of the
study methods. Authors achieved consensus on the 12
articles with the highest ratings. Key summary findings
of the 12 studies are highlighted in Table 1.
Pharmacotherapy for Acute Lumbar Pain
• Friedman BW, Dym AA, Davitt M, et al. Naproxen
with cyclobenzaprine, oxycodone/acetaminophen, or
placebo for treatment of acute low back pain. JAMA
2015;314(15):1572–80 [3].
• Goldberg H, Firtch W, Tyburski M, et al. Oral steroids for
acute radicular pain due to herniated disc: A randomized
controlled trial. JAMA 2015;313(19):1915–23 [4].
Pharmacotherapy is usually the firstline treatment for
acute low back pain and may include nonsteroidal anti-
inflammatory drugs (NSAIDS), acetaminophen, skeletal
muscle relaxants, oral steroids, or opioids. These medi-
cations are frequently used in combination to achieve
greater pain relief despite a paucity of studies examining
the effectiveness of combination therapy in the emer-
gency or urgent care setting. In patients who present
with acute low back pain and radiculopathy due to a
herniated disc, oral steroids are commonly prescribed
to hasten recovery and prevent the need for invasive
treatments. Until recently, the use of oral steroids for
radiculopathy due to a herniated disc was only sup-
ported by small, inadequately powered studies.
Friedman et al. evaluated whether combination pharma-
cotherapy was more effective than monotherapy with
naproxen in patients with acute low back pain who pre-
sented to the emergency department. Using change in
the Roland-Morris Disability Questionnaire, a measure of
pain and function, at one-week as the primary outcome,
the trial compared three treatment arms: 1) naproxen
plus placebo; 2) naproxen plus cyclobenzaprine; and 3)
naproxen plus oxycodone/acetaminophen. At one
week, there was no significant difference in pain and
function between treatment groups. Of note, patients
who received combination therapy reported more side
effects than those who received naproxen plus placebo.
In a related study, Goldberg et al. examined whether
oral prednisone was more effective than placebo among
patients with acute sciatica due to a magnetic reso-
nance imaging (MRI)–confirmed herniated disc. Using
change in the Oswestry Disability Index, a measure of
pain and function, at three weeks as the primary out-
come, the study compared a tapering 15-day course of
oral prednisone to matching placebo. Both treatment
groups improved on the primary outcome measure from
baseline. However, there were adjusted differences be-
tween treatment arms of 6.4 points at three weeks and
7.4 points at 52 weeks, favoring the prednisone arm at
both time points, albeit modestly. Adverse events were
more frequent in the prednisone group, but were gener-
ally mild and short-lived.
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Table 1 Key summary points by study
Category Study Key Summary Points
Pharmacothera-
py for acute
lumbar pain
Friedman BW, Dym AA, Davitt M, et al.
Naproxen with cyclobenzaprine, oxyco-
done/acetaminophen, or placebo for
treatment of acute low back pain.
JAMA 2015;314(15):1572–80 [3].
• In patients with acute, nonradicular low back
pain who presented to an emergency depart-
ment, the addition of cyclobenzaprine or oxyco-
done/acetaminophen to naproxen alone did not
improve pain or function at one week and led to
more side effects.
Goldberg H, Firtch W, Tyburski M, et al.
Oral steroids for acute radicular pain
due to herniated disc: A randomized
controlled trial. JAMA
2015;313(19):1915–23 [4].
• In patients with acute sciatica due to MRI-con-
firmed herniated disc, oral prednisone led to a
modest, statistically significant improvement in
back pain-related function at three weeks.
Interventional
pain
treatments
Chou R, Hashimoto R, Friedly J, et al.
Epidural corticosteroid injections for
radiculopathy and spinal stenosis: A
systematic review and meta-analysis.
Ann Intern Med 2015;163:373–81 [5].
• Epidural steroid injection (ESI) did not show
long-term benefit and showed small benefit of
questionable clinical significance in the immedi-
ate or short term.
• Source studies were insufficient to pool data
and draw conclusions about the harms of ESI.
Skou ST, Roos EM, Laursen MB, et al.
A randomized, controlled trial of total
knee replacement. N Engl J Med
2015;373:1597–606 [8].
• Total knee replacement (TKR) was more effica-
cious than nonsurgical management for pain
and functional improvement in individuals with
knee OA. Improvement was sustained at
12months.
• TKR was associated with higher risk for adverse
events.
Medical canna-
bis or cannabi-
noids for pain
Whiting PF, Wolff RF, Deshpande S,
et al. Cannabinoids for medical use: A
systematic review and meta-analysis.
JAMA 2015;313(24):2456–73 [11].
• There is evidence for the efficacy of medical
cannabinoids in chronic neuropathic pain based
on the pooled results from six studies of
15weeks or shorter duration.
• The pooled treatment effect was modest, and
adverse effects were common.
• The quality of evidence was low to moderate,
and there was significant risk of bias.
Complementary
and integrative
medicine for
low back pain
Morone NE, Greco CM, Moore CG,
et al. A mind-body program for older
adults with chronic low back pain: A
randomized clinical trial. JAMA Intern
Med 2016;176(3):329–37 [12].
• Clinically meaningful functional improvement
was greater in the mindfulness meditation group
than the health education group at eight weeks
but did not differ at six months.
Cherkin DC, Sherman KJ, Balderson
BH, et al. Effect of mindfulness-based
stress reduction vs cognitive behav-
ioral therapy or usual care on back
pain and functional limitations in adults
with chronic low back pain: A random-
ized clinical trial. JAMA
2016;315(12):1240–9 [13].
• Clinically meaningful functional improvement
was achieved by a significantly greater propor-
tion of participants in the MBSR and CBT
groups at 26weeks compared with usual care
recipients. Improvements in the MBSR group
persisted at 52weeks.
Collaborative
care manage-
ment in
chronic mus-
culoskeletal
pain
Kroenke K, Krebs EE, Wu J, Yu Z,
Chumbler NR, Bair MJ. Telecare col-
laborative management of chronic pain
in primary care. A randomized clinical
trial. JAMA 2014;312:240–8 [20].
• At 12months, the Telecare Collaborative
Management (TCM) group had a clinically sig-
nificant improvement in pain and function com-
pared with usual care.
• TCM participants were more likely to rate as
good to excellent both medication prescribed for
their pain and overall treatment of their pain.
(continued)
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Implications for Practice
In patients with acute, nonradicular low back pain who
present to an emergency department, the addition of
cyclobenzaprine or oxycodone/acetaminophen to nap-
roxen alone did not improve pain or function at 1 week
and led to more side effects. As such, the study by
Friedman et al. provides evidence against the use of
combination therapy in the emergency setting for acute
low back pain. Treatment with naproxen alone provides
similar benefits and avoids the added side effects of
combination therapy. Relatedly, in patients with acute
sciatica due to MRI-confirmed herniated disc, oral predni-
sone led to a modest, statistically significant improvement
in back pain–related function. An important caveat related
to these studies is that they were both performed in
the emergency setting where patients presenting with
acute back pain may differ in important ways from pa-
tients presenting to urgent or primary care settings. Also,
as with any recommended therapy, risks and potential
benefits of pharmacotherapy need to be discussed with
patients.
Interventional Pain Treatments
• Chou R, Hashimoto R, Friedly J, et al. Epidural corti-
costeroid injections for radiculopathy and spinal ste-
nosis: A systematic review and meta-analysis. Ann
Intern Med 2015;163:373–81 [5].
Lumbar radiculopathy (sciatica) and spinal stenosis are
common conditions [6]. Epidural steroid injection (ESI) is
an increasingly used interventional treatment for lumbar
radiculopathy and spinal stenosis. However, given the pre-
dominance of small studies with heterogeneous compara-
tors and outcomes, the evidence base for ESI is unclear.
Therefore, the US Centers for Medicare and Medicaid
Services requested a systematic review and meta-analysis
of the literature, which included randomized controlled tri-
als comparing ESI with placebo (no injection; or saline, lo-
cal anesthetic, or subcutaneous injection). Eligible studies
involved adult participants with lumbar radiculopathy or
spinal stenosis of any duration but not due to trauma, in-
fection, or cancer. Outcomes were categorized as imme-
diate (five days to two weeks), short term (two weeks to
Table 1 Continued
Category Study Key Summary Points
Bair MJ, Ang D, Wu J, Outcalt SD,
Sargent C, et al. Evaluation of
Stepped Care for Chronic Pain
(ESCAPE) in veterans of the Iraq and
Afghanistan conflicts: A randomized
clinical trial. JAMA Intern Med
2015;175:682–9 [21].
• The stepped care group experienced clinically
significant improvements in three coprimary out-
comes related to pain and pain-related interfer-
ence compared with usual care.
Prevention Steffans D, Maher CG, Pereira LSM,
et al. Prevention of low back pain: A
systematic review and meta-analysis.
JAMA Intern Med 2016;176(2):199–
208 [23].
• For exercise alone, pooled results of four trials
provided low-quality evidence of a short-term
protective effect of exercise on incident low back
pain (LBP).
• Exercise plus education reduced incident LBP at
short-term and long-term follow-up but had no
effect on prevention of LBP-related sick leave at
short- or long-term follow-up.
Dunlop DD, Song J, Semanik PA, et al.
Relation of physical activity time to in-
cident disability in community dwelling
adults with or at risk of knee osteoar-
thritis: A prospective cohort study.
BMJ 2014;348:g2472 [24].
• Increasing amounts of time per day spent in
light-intensity physical activities were signifi-
cantly associated with less incident disability
and less disability progression, even after con-
trolling for socioeconomic and clinical factors.
White DK, Tudor-Locke C, Zhang Y, et al.
Daily walking and the risk of incident
functional limitation in knee osteoarthritis:
An observational study. Arthritis Care
Res 2014;66(9):1328–36 [25].
• This study demonstrated a dose-response rela-
tionship between increased steps and de-
creased disability.
Abbreviations: CBT ¼ Cognitive behavioral therapy; ESI ¼ Epidural steroid injection; LBP ¼ Low back pain; MBSR ¼
Mindfulness-based stress reduction; MRI ¼ Magnetic resonance imaging; TCM ¼ Telecare collaborative management; TKR ¼
Total knee replacement;
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three months), intermediate (three months to 12 months),
or long term (more than 12 months).
Thirty trials for lumbar radiculopathy and eight for spinal
stenosis were included. For lumbar radiculopathy,
pooled results demonstrated a significant but small ben-
eficial effect of ESI compared with placebo in both im-
mediate pain (mean difference ¼ 7.55, 95%
confidence interval [CI] ¼ 11.4 to 3.7) and function
(mean difference ¼ 0.33, 95% CI¼0.56 to 0.09),
as well as short-term risk of proceeding to surgery (rela-
tive risk [RR] ¼ 0.62, 95% CI ¼ 0.41 to 0.92). For spinal
stenosis, the pooled results demonstrated a significant
but small beneficial effect of ESI compared with placebo
only in immediate pain (mean difference ¼ 22.0, 95%
CI¼0.36 to 8.0). No intermediate or long-term
pooled effects were statistically significant for lumbar
radiculopathy or spinal stenosis. There were no clear
differences by corticosteroid formulation, dose, anatomi-
cal approach, or patient characteristics. Serious adverse
events were rare, but inconsistency in assessing and re-
porting harms limits the conclusions that can be drawn.
Implications for Practice
The results of this study should help providers counsel
patients about the expected benefits of ESI treatment for
lumbar radiculopathy or spinal stenosis. In this meta-
analysis, ESI did not show benefit in the long-term and
showed small benefit of questionable clinical significance
in the immediate or short term. The source studies were
insufficient to pool data and draw conclusions about the
harms of ESI. While this review demonstrated only mod-
est efficacy for ESI for immediate and short-term out-
comes, patients with severe and persistent symptoms
despite conservative interventions may still warrant refer-
ral to interventional pain management, particularly when
seeking short-term improvement in symptoms [7].
• Skou ST, Roos EM, Laursen MB, et al. A randomized,
controlled trial of total knee replacement. N Engl J
Med 2015;373:1597–606 [8].
Total knee replacement (TKR) for osteoarthritis (OA) is
common and increasing, with over 670,000 TKRs per-
formed in the United States each year, a seven-fold in-
crease since the 1970s [9]. Recent clinical guidelines
recommend nonsurgical treatment as core therapy for
knee OA [10]. These treatments include exercise, edu-
cation, diet modification, use of shoe insoles, and medi-
cations. However, there were no prior high-quality
randomized controlled trials of TKR compared with
nonsurgical treatment for knee OA.
Skou et al. performed a randomized controlled trial ex-
amining whether TKR was more effective than nonsurgi-
cal management for patients with knee OA deemed
eligible for TKR by an orthopedic surgeon. With the pri-
mary outcome of 12-month change in the Knee Injury
and Osteoarthritis Outcome Score (KOOS4), a measure
of pain, symptoms, function, and quality of life
measured from 0 to 100, the study compared: 1) 12
weeks of nonsurgical management (exercise for 60 min-
utes twice weekly, two educational sessions, four die-
tary advice sessions, individually fitted insoles, and
analgesics [acetaminophen or ibuprofen]) vs 2) TKR fol-
lowed by 12 weeks of the same nonsurgical manage-
ment. Secondary outcomes included symptoms,
medication use, and adverse events.
Both treatment groups improved on the KOOS4 at
12 months, but in the intention-to-treat analysis, there
was significantly greater improvement in the primary
outcome and all secondary outcomes for the TKR group
compared with the nonsurgical group. The number
needed to treat with TKR instead of nonsurgical man-
agement to achieve one additional beneficial outcome
was 5.7. However, there were significantly more adverse
events in the TKR group than in the nonsurgical group,
Implications for Practice
TKR is more efficacious than nonsurgical management
for pain and functional improvement in individuals with
knee OA, and improvement was sustained at
12 months. However, TKR is associated with higher risk
for adverse events. Thus, providers should discuss pa-
tients’ preferences and values and use shared decision-
making when considering TKR for knee OA. While some
patients will choose TKR given the improvement in 12-
month outcomes, some patients may prefer to intensify
nonsurgical management to avoid risks of TKR.
Medical Cannabis or Cannabinoids for Pain
• Whiting PF, Wolff RF, Deshpande S, et al.
Cannabinoids for medical use: A systematic review
and meta-analysis. JAMA 2015;313(24):2456–73 [11].
While 23 states and the District of Columbia now allow
medical cannabis, its role in various conditions including
chronic pain management remains controversial.
Whiting et al. performed a systematic review and meta-
analysis to evaluate the evidence for efficacy and harms
of medical cannabinoids. While the authors assessed a
broad range of potential benefits in multiple conditions,
our review is limited to the effects on chronic pain.
Using a broad search strategy, the authors sought to
identify all published and unpublished studies of ran-
domized controlled trials comparing cannabinoids with
either placebo, usual care, or no treatment for 10
prespecified conditions including chronic pain through
April 2015. After applying a set of inclusion criteria, the
remaining studies were assessed using the Grading of
Recommendations Assessment, Development and
Evaluation (GRADE) system and categorized by the
Cochrane Risk of Bias Tool. Twenty-eight studies re-
lated to chronic pain management including 2,454 par-
ticipants were identified. A plurality of studies involved
neuropathic pain (N¼ 12), with three examining effects
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in cancer pain and two in fibromyalgia. Of the 28 stud-
ies, 13 examined the oral mucosal spray nabiximols and
four examined smoked cannabis. Two studies were
deemed at low risk of bias, nine at unclear risk, and 17
at high risk of bias.
For several pain-related outcomes, there was a modest,
statistically significant improvement with cannabinoids. Eight
studies of moderate quality were deemed eligible for meta-
analysis: one studied smoked cannabis, and seven exam-
ined nabiximols; six of these eight studied neuropathic pain.
In the meta-analysis, pooled estimates were determined us-
ing random-effects models; the average number of patients
who reported a reduction in pain severity of at least 30%
using the 10-point pain numerical rating scale (NRS) was
greater with cannabinoids than with placebo (odds ratio
[OR] ¼ 1.41, 95% CI ¼ 0.99 to 2.00). Among the six
nabiximols studies, a weighted mean difference (WMD) of
0.46 (95% CI ¼0.80 to0.11) on the NRS was found
favoring nabiximols. Similarly, a WMD of 3.9 (95% CI
¼7.32 to0.47) favoring cannabinoids was seen in five
studies examining the 100-point neuropathic pain scale. No
difference was found in the three studies that used the
Brief Pain Inventory or the three studies that assessed qual-
ity of life. Importantly, no study was longer than 15weeks.
Whiting et al. also meta-analyzed data on adverse events re-
lated to medical cannabis, pooling the results across indica-
tions. For the 29 studies reporting any adverse event, there
was a greater risk in the cannabinoid treatment groups (OR
¼ 3.0, 95% CI ¼ 2.4 to 3.8). Similarly, cannabinoids were
associated with greater risk of serious adverse events (OR ¼
1.4, 95% CI ¼ 1.0 to 1.9, 34 studies) and withdrawal from
the study (OR ¼ 2.9, 95% CI ¼ 2.2 to 4.0, 23 studies). Most
common adverse effects were neuropsychiatric symptoms
such as dizziness, confusion, and disorientation, each with
an OR between 4 and 5, demonstrating strong associations
with cannabinoid treatment.
Implications for Practice
This systematic review and meta-analysis concluded
that there is evidence for the efficacy of medical canna-
binoids in chronic neuropathic pain based on the pooled
results from six studies of 15 weeks or shorter duration.
The pooled treatment effect was modest, and adverse
effects were common. Further, the quality of evidence
was low to moderate, and there was significant risk of
bias. Therefore, clear scientific evidence to guide prac-
tice is lacking while access to medical cannabis ex-
pands. In light of this conundrum, we suggest that
PCPs discuss the known risks and potential benefits
with patients, make individualized treatment decisions,
and, importantly, provide close follow-up if medical can-
nabis use is authorized to assess harm and benefit.
Complementary and Integrative Medicine for Low
Back Pain
• Morone NE, Greco CM, Moore CG, et al. A mind-
body program for older adults with chronic low back
pain: A randomized clinical trial. JAMA Intern Med
2016;176(3):329–37 [12].
• Cherkin DC, Sherman KJ, Balderson BH, et al. Effect
of mindfulness-based stress reduction vs cognitive
behavioral therapy or usual care on back pain and
functional limitations in adults with chronic low back
pain: A randomized clinical trial. JAMA
2016;315(12):1240–9 [13].
Nearly 18 million U.S. adults practiced some form of
meditation in 2012 [14]. Little is known about the effec-
tiveness of mindfulness meditation for musculoskeletal
pain [15]. Two randomized controlled trials examined
the effectiveness of a mindfulness meditation program
in adults with functional limitations due to chronic low
back pain. In a trial by Morone et al., 282 older adults
(mean age ¼ 75 years, 66% women) were randomized
to an eight-week mindfulness meditation program or a
health education program. In a trial by Cherkin et al.,
342 adults (mean age ¼ 49 years, 66% women) were
randomized to an eight-week mindfulness-based stress
reduction (MBSR) program [16], a cognitive behavioral
therapy (CBT) group program, or usual care. Eleven per-
cent of participants used opioid medication for back
pain, with no significant difference across intervention
groups.
In the study of older adults by Morone et al., the primary
outcome measure was the Roland-Morris Disability
Questionnaire (RMDQ), a measure of functional limita-
tions as a result of back pain. Clinically meaningful func-
tional improvement was greater in the mindfulness
meditation group than the health education group at
eight weeks (57% vs 45%, P ¼ 0.051). This difference
was not sustained at six months as 49% of participants
in both groups experienced clinically meaningful im-
provement at six months (P ¼ 0.97). Among secondary
outcomes, participants in the mindfulness meditation
group were more likely to report a clinically meaningful
improvement in most severe pain (36% vs 22%, P ¼
0.02) and marked improvement in back pain symptoms
(45% vs 8%, P < 0.01) at six months. In the study by
Cherkin et al., clinically meaningful functional improve-
ment as measured by a modified RMDQ was achieved
by 61% and 58% of participants in the MBSR and CBT
groups at 26 weeks, respectively, compared with 44%
of usual care recipients (P ¼ 0.04). Also at 26 weeks,
clinically meaningful improvement in “bothersomeness”
of pain was reported by 44% and 45% of participants in
the MBSR and CBT groups, respectively, vs 27% of
usual care recipients (P ¼ 0.01). Findings for the MBSR
group persisted at 52 weeks for both outcomes.
Differences between MBSR and CBT were not signifi-
cant for either outcome at 26 or 52 weeks. In both trials,
there were no serious adverse events reported.
Implications for Practice
These studies of mindfulness-based approaches to
chronic low back pain address the urgent need for
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additional evidence-based, nonpharmacologic therapies
for low back pain. The clinically meaningful short- and
long-term benefits and infrequent adverse events seen
in these studies should prompt providers, educators,
policy-makers, and payers to consider incorporating
mindfulness meditation into their approaches to sup-
porting patient-centered, multimodal pain care. First,
providers should ask their patients about their experi-
ences with nonpharmacologic modalities such as mind-
fulness meditation or CBT [17,18]. Second, widespread
adoption of nonpharmacologic pain care in primary care
settings will require training that is typically absent from
current medical school and residency curricula. In the
short term, providers can avail themselves of existing
educational opportunities. In the long term, however,
mindfulness meditation and other nonpharmacologic
modalities should be taught alongside pharmacotherapy
as a core competency of chronic pain care. Finally, pa-
tients’ access to in-person, nonpharmacologic pain care
is currently inadequate. Providers should identify avail-
able nonpharmacologic treatment options in their com-
munities as well as within the rapidly growing
community of web-based and mobile pain self-
management resources [19].
Collaborative Care Management in Chronic
Musculoskeletal Pain
• Kroenke K, Krebs EE, Wu J, Yu Z, Chumbler NR, Bair
MJ. Telecare collaborative management of chronic
pain in primary care. A randomized clinical trial. JAMA
2014;312:240–8 [20].
• Bair MJ, Ang D, Wu J, Outcalt SD, Sargent C, et al.
Evaluation of Stepped Care for Chronic Pain
(ESCAPE) in veterans of the Iraq and Afghanistan
conflicts: A randomized clinical trial. JAMA Intern Med
2015;175:682–9 [21].
With the widespread prevalence of chronic pain, primary
care providers must be engaged and activated to serve
as effective firstline treatment providers and coordinate
the patient’s pain care. In the care of other chronic con-
ditions, collaborative care management protocols deliv-
ered by nonphysicians in tandem with physicians can
be effective, efficient, and can lead to improved patient
satisfaction [22]. These two studies sought to test the
effectiveness of nurse care manager–led interventions
with physician oversight to optimize chronic pain care
using algorithm-based, frequent-contact treatment
approaches.
Kroenke et al.’s intervention (N¼ 249) used phone or
internet-based automated symptom monitoring as inputs
for a 12-month, nurse-administered, physician-supervised
medication optimization algorithm. Bair et al.’s intervention
(N¼ 241) was a stepped-care approach in which partici-
pants first underwent 12 weeks of protocol-driven medica-
tion optimization and then 12 weeks of cognitive-
behavioral therapy (CBT), all administered by a nurse who
was supervised by a physician. Both studies tested their
interventions in Veterans Health Administration (VA) primary
care settings among mostly male, mostly white partici-
pants who had chronic musculoskeletal pain. While the
primary outcome for Kroenke et al. was change from
baseline in the Brief Pain Inventory (BPI) severity module,
Bair et al. examined three coprimary outcomes: 1) change
from baseline in the 24-item Roland Morris Disability
Questionnaire, 2) BPI interference subscale, and 3) the
Graded Chronic Pain scale.
At 12 months, Kroenke et al.’s intervention group had a
clinically significant 1.02-point improvement in BPI total
score (95% CI ¼1.58 to0.47) compared with the con-
trol group. Furthermore, intervention group participants
were more likely to rate as good to excellent both medica-
tion prescribed for their pain (73.9% vs 50.9%, RR ¼ 1.5,
95% CI ¼ 1.2 to 1.8) and overall treatment of their pain
(76.7% vs 51.6%, RR ¼ 1.5, 95% CI ¼ 1.2 to 1.8). In
Bair et al., the intervention group experienced clinically sig-
nificant improvements in each coprimary outcome: at nine
months, the mean decrease from baseline in the Roland
Morris Disability Scale score was 3.7 (95% CI ¼4.5
to2.8) points, the mean decrease in the pain interfer-
ence subscale score of the BPI was 1.7 points (95% CI ¼
2.1 to 1.3), and the Graded Chronic Pain Scale sever-
ity score was reduced by 11.1 points (95% CI¼13.9 to
8.3). With each outcome, these effects were statistically
greater than those experienced by the control group.
Furthermore, the intervention group’s receipt of multimodal
pain treatment was demonstrated by a mean of 5.6 tele-
phone sessions to discuss self-management strategies
and 3.6 CBT sessions.
Implications for Practice
First, these two studies demonstrated effectiveness of
interventions on clinically significant pain and functional
outcomes for patients with chronic pain. Second, using
team-based care—pairing a nurse with a primary care
physician—these interventions seem feasible and gener-
alizable in that they avoided reliance on sometimes
hard-to-access specialty care. Third, Bair et al. particu-
larly demonstrated that multimodal, nonpharmacologic
treatment can be integrated into primary care. Though
neither study assessed system-level process outcomes
(e.g., efficiency of care, ability of physicians to address
other clinical problems more readily), these interventions
may promote these important outcomes as well and
should be studied in non-VA settings. While innovative
care models are sometimes challenging to implement in
fee-for-service settings, collaborative care models’
leveraging of the skills and expertise of less expensive
staff may prove cost-effective.
Prevention
• Steffans D, Maher CG, Pereira LSM, et al. Prevention
of low back pain: A systematic review and meta-
analysis. JAMA Intern Med 2016;176(2):199–208 [23].
• Dunlop DD, Song J, Semanik PA, et al. Relation of
physical activity time to incident disability in commu-
nity dwelling adults with or at risk of knee
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osteoarthritis: A prospective cohort study. BMJ
2014;348:g2472 [24].
• White DK, Tudor-Locke C, Zhang Y, et al. Daily walk-
ing and the risk of incident functional limitation in knee
osteoarthritis: An observational study. Arthritis Care
Res 2014;66(9):1328–36 [25].
Back pain is the leading cause of disability in the United
States and worldwide [26], OA is the ninth leading
cause of disability in United States, and hip/knee OA is
the 11th leading cause worldwide [27]. Given this con-
siderable burden, successful prevention of acute to
chronic pain transition would have widespread public
health impact.
Steffans et al. performed a systematic review and meta-
analysis to evaluate the evidence on the effectiveness of
interventions for prevention of low back pain (LBP) and
sick leave due to LBP. They included randomized con-
trolled trials comparing prevention strategies with pla-
cebo, no intervention, or minimal intervention that aimed
to prevent future episodes of LBP or sick leave due to
LBP among participants without LBP at baseline.
Outcome data were extracted for short-term
(12 months) and long-term (>12 months) follow-up.
Twenty-one trials (total N¼ 30,850 participants) were in-
cluded, examining six categories of prevention strate-
gies: exercise; exercise plus education; education; back
belts; shoe insoles; and other. For exercise alone,
pooled results of four trials provided low-quality evi-
dence of a short-term protective effect of exercise on in-
cident LBP (0.65, 95% CI¼ 0.50 to 0.86). However,
exercise plus education reduced incident LBP at short-
term (0.55, 95% CI¼ 0.41 to 0.74, four trials) and long-
term follow-up (0.73, 95% CI¼ 0.55 to 0.96, two trials)
but had no effect on prevention of LBP-related sick
leave at short or long-term follow-up. The authors found
moderate-quality evidence for no effect of education
alone and no effect for back belts, as well as low-quality
evidence for no effect of shoe insoles.
Dunlop et al. and White et al. published similar observa-
tional studies assessing the impact of physical activity
on incident disability among adults with (or at risk of)
knee OA. Dunlop et al. followed 1,680 community-
dwelling adults age 49 years and older at risk of knee
OA over two years and assessed the impact of light
physical activity (using accelerometer readings) on inci-
dent disability, defined as difficulty or dependency in
carrying out activities essential to independent living.
The study demonstrated that increasing quartile catego-
ries of daily time spent in light-intensity physical activities
was significantly associated with less incident disability
and less disability progression, even after controlling for
socioeconomic and clinical factors. Similarly, White et al.
followed a prospective cohort of older adults (N¼1,788)
with or at risk of knee OA and examined the association
between baseline activity—measured as walking steps
over a seven-day period—and incident functional limita-
tion at two years. This study demonstrated a dose-
response relationship between steps and decreased
disability: Each additional 1,000 steps per day at base-
line was associated with a 16% and 18% reduction in
incident functional limitation by performance-based and
self-report measures, respectively.
Implications for Practice
Exercise interventions are effective for reducing risk of
subsequent back pain, and small differences in low-
intensity physical activity are associated with substan-
tial decreased risk of incident disability. As stated by
Carey and Freburger in a commentary accompanying
the Steffans et al. review, “If a medication or injection
were available that reduced LBP recurrence by such
an amount, we would be reading the marketing mate-
rials in our journals and viewing them on television”
[28]. These studies should prompt providers to in-
crease their focus on prevention for patients at risk of
recurrent back pain or OA-related disability including
counseling patients on increasing and maintaining low-
intensity exercise and referring patients for group or in-
dividual exercise instruction. More research is needed
on optimal methods for increasing patient motivation
and improving implementation of evidence-based exer-
cise interventions.
Discussion
In addition to the key summary findings displayed in
Table 1, in this review of high-impact pain management
studies relevant to primary care providers, several im-
portant themes emerged. First, the studies highlighted
the need for continued progress toward pain care that
is systematic, multidisciplinary, and patient-centered.
Second, the growing evidence for cognitive behavioral,
mindfulness-based, and exercise-based interventions in
the management of chronic pain has clear implications
for practice, medical education, and policy-making.
Given the public health threat of opioid use disorder and
overdose and the lack of clear benefit of opioids for
chronic pain, primary care providers should embrace
these nonopioid treatments whenever possible. Third,
given the growing access to cannabinoids for medical
indications, including chronic pain, this review adds to
the growing calls for high-quality research examining
short- and long-term outcomes. Fourth, in an era where
integrated health systems need to make difficult choices
about resource allocation, these findings can inform de-
cisions on the balance of interventional to noninterven-
tional services available. On the other hand, with TKR’s
value in improving pain and function in knee OA, we ad-
vocate for improved access to the surgery for patients
who would potentially benefit from it. Finally, collabora-
tive care management protocols, where nurses or other
providers partner with physicians to deliver effective
multimodal chronic pain care, offer a promising path for
bringing pain management up to speed with successful
primary care–based disease management paradigms for
treating other chronic conditions.
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